Stock listing
Tradegate:12V Veracyte, Inc. Aktie
German listing (Tradegate) of Veracyte, Inc. · home listing NASDAQ:VCYT
Follow Veracyte, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:VCYT
$50.01 USD -2.16 (-4.1%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:VCYT
- Day range
- $49.65 – $51.93 USDOct 30, 2026
- Volume
- 1.02M sharesOct 30, 2026
- Market cap
- $4.02B USDAt the close on Oct 30, 2026 · price × 80.39M shares outstanding
- 52-week range
- $29.46 – $60.91 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $62.00M USDMedian day 1.23M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:VCYT · Home | $50.01 USD | -2.16 (-4.1%) | 1,015,333 | $51.54 | $51.93 | $49.65 | $52.17 | Close on Oct 30, 2026 |
| Frankfurt:12V | €45.49 EUR | +2.29 (+5.3%) | — | €45.49 | €45.49 | €45.49 | €43.20 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:VCYT · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $50.01 | -2.16 | -4.1% | $51.54 | $51.93 | $49.65 | 1,015,333 | |
| $52.17 | +1.86 | +3.7% | $50.82 | $52.39 | $49.63 | 1,231,141 | |
| $50.31 | +0.03 | +0.1% | $50.00 | $51.79 | $49.87 | 1,397,992 | |
| $50.28 | +2.08 | +4.3% | $48.06 | $52.25 | $47.33 | 1,809,888 | |
| $48.20 | +0.27 | +0.6% | $48.24 | $48.96 | $47.70 | 748,098 | |
| $47.93 | +1.89 | +4.1% | $45.87 | $48.07 | $45.48 | 906,000 | |
| $46.04 | -0.18 | -0.4% | $45.98 | $46.63 | $45.29 | 1,203,500 | |
| $46.22 | +1.43 | +3.2% | $44.17 | $46.43 | $43.90 | 812,300 | |
| $44.79 | +0.99 | +2.3% | $43.91 | $45.17 | $43.47 | 1,136,400 | |
| $43.80 | +0.68 | +1.6% | $43.70 | $45.01 | $43.45 | 725,400 | |
| $43.12 | -1.27 | -2.9% | $45.00 | $45.75 | $42.83 | 2,063,200 | |
| $44.39 | +0.88 | +2.0% | $43.36 | $45.58 | $42.70 | 1,227,200 | |
| $43.51 | +0.40 | +0.9% | $42.37 | $43.99 | $42.20 | 935,300 | |
| $43.11 | -0.91 | -2.1% | $43.67 | $44.29 | $43.04 | 760,400 | |
| $44.02 | -1.21 | -2.7% | $45.18 | $45.22 | $43.29 | 1,151,600 | |
| $45.23 | +1.63 | +3.7% | $43.71 | $46.17 | $43.50 | 966,500 | |
| $43.60 | +0.44 | +1.0% | $42.50 | $43.67 | $41.22 | 1,221,600 | |
| $43.16 | -1.49 | -3.3% | $44.04 | $44.21 | $42.34 | 1,213,600 | |
| $44.65 | -3.02 | -6.3% | $48.00 | $48.84 | $44.09 | 1,730,800 | |
| $47.67 | +1.86 | +4.1% | $45.75 | $47.79 | $45.00 | 1,289,100 | |
| $45.81 | +1.62 | +3.7% | $44.94 | $46.09 | $44.41 | 1,041,700 | |
| $44.19 | -1.85 | -4.0% | $45.66 | $47.14 | $44.18 | 1,426,700 | |
| $46.04 | -0.04 | -0.1% | $45.93 | $46.78 | $45.60 | 1,184,200 | |
| $46.08 | +0.85 | +1.9% | $46.00 | $47.52 | $45.21 | 1,594,800 | |
| $45.23 | -0.20 | -0.4% | $45.04 | $47.52 | $44.47 | 1,696,500 | |
| $45.43 | -3.11 | -6.4% | $49.00 | $49.00 | $45.36 | 1,725,700 | |
| $48.54 | +4.72 | +10.8% | $43.66 | $48.95 | $43.51 | 2,880,200 | |
| $43.82 | +0.46 | +1.1% | $42.95 | $43.86 | $42.25 | 1,525,500 | |
| $43.36 | +1.84 | +4.4% | $41.76 | $43.74 | $41.32 | 1,472,500 | |
| $41.52 | +1.725 | +4.3% | $40.00 | $41.98 | $39.40 | 1,470,500 | |
| $39.80 | -0.775 | -1.9% | $40.41 | $41.05 | $39.55 | 2,667,600 | |
| $40.57 | +2.07 | +5.4% | $39.67 | $40.70 | $38.80 | 1,470,300 | |
| $38.50 | -1.64 | -4.1% | $40.36 | $41.45 | $38.25 | 1,622,100 | |
| $40.14 | -1.07 | -2.6% | $40.83 | $42.36 | $39.10 | 1,760,600 | |
| $41.21 | +0.34 | +0.8% | $41.17 | $41.40 | $40.50 | 1,032,500 | |
| $40.87 | -1.16 | -2.8% | $42.61 | $42.66 | $40.79 | 1,001,600 | |
| $42.03 | -1.83 | -4.2% | $43.18 | $43.78 | $41.64 | 849,400 | |
| $43.86 | +1.41 | +3.3% | $42.79 | $44.20 | $42.39 | 1,450,100 | |
| $42.45 | -0.08 | -0.2% | $41.81 | $43.28 | $41.57 | 962,000 | |
| $42.53 | -2.14 | -4.8% | $44.21 | $44.81 | $42.43 | 992,000 | |
| $44.67 | -0.21 | -0.5% | $45.36 | $45.99 | $44.12 | 673,700 | |
| $44.88 | +1.45 | +3.3% | $43.51 | $45.65 | $43.48 | 1,371,700 | |
| $43.43 | +0.24 | +0.6% | $42.97 | $43.74 | $42.28 | 873,000 | |
| $43.19 | -0.15 | -0.3% | $42.33 | $43.34 | $41.60 | 1,472,100 | |
| $43.34 | -1.91 | -4.2% | $45.21 | $45.55 | $43.32 | 1,684,100 | |
| $45.25 | +0.96 | +2.2% | $44.20 | $45.50 | $44.19 | 1,328,200 | |
| $44.29 | +0.25 | +0.6% | $43.78 | $44.52 | $43.25 | 2,181,500 | |
| $44.04 | +2.57 | +6.2% | $42.01 | $44.10 | $41.81 | 1,155,347 | |
| $41.47 | -0.84 | -2.0% | $42.00 | $42.07 | $41.02 | 1,165,433 | |
| $42.31 | +0.52 | +1.2% | $42.18 | $42.54 | $41.10 | 1,005,500 | |
| $41.79 | -0.40 | -0.9% | $41.67 | $42.45 | $41.05 | 980,400 | |
| $42.19 | +1.51 | +3.7% | $41.92 | $42.52 | $40.10 | 1,761,600 | |
| $40.68 | -1.40 | -3.3% | $41.80 | $42.35 | $40.35 | 1,143,200 | |
| $42.08 | +0.83 | +2.0% | $40.96 | $42.50 | $40.96 | 1,574,000 | |
| $41.25 | -1.35 | -3.2% | $42.54 | $43.13 | $41.00 | 1,669,400 | |
| $42.60 | -2.08 | -4.7% | $45.23 | $45.23 | $42.51 | 1,454,900 | |
| $44.68 | -1.73 | -3.7% | $46.55 | $46.76 | $44.28 | 874,000 | |
| $46.41 | +0.14 | +0.3% | $46.07 | $46.67 | $45.72 | 551,006 | |
| $46.27 | -0.95 | -2.0% | $46.87 | $47.75 | $46.12 | 761,912 | |
| $47.22 | +1.07 | +2.3% | $47.00 | $47.80 | $46.21 | 821,300 | |
| $46.15 | 0.00 | 0.0% | $45.80 | $46.53 | $45.16 | 939,800 | |
| $46.15 | -0.26 | -0.6% | $46.07 | $47.96 | $45.92 | 1,227,700 | |
| $46.41 | +1.56 | +3.5% | $44.84 | $46.57 | $43.09 | 1,987,100 | |
| $44.85 | -1.47 | -3.2% | $46.36 | $47.32 | $44.81 | 2,010,900 | |
| $46.32 | -13.46 | -22.5% | $48.77 | $50.17 | $43.52 | 5,994,800 | |
| $59.78 | +4.07 | +7.3% | $55.36 | $59.96 | $54.73 | 1,541,300 |
- Ticker
- Tradegate:12V
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- Tradegate
- Currency
- EUR
What changed lately
Latest news release · Oct 29, 2026
Veracyte to Participate in Upcoming Investor Conferences
Latest earnings call · Jul 30, 2026
Veracyte (NASDAQ:VCYT) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Jul 30, 2026
Q2 2026 Earnings Presentation
Earnings · 23 slides
Calls
Upcoming
Veracyte (NASDAQ:VCYT) Q3 2026 Earnings Call
Wed, Nov 04, 2026 · 4:30 PM ET
Register
Replays
Veracyte (NASDAQ:VCYT) Q2 2026 Earnings Call
Thu, Jul 30, 2026 · 4:30 PM ET
Watch TranscriptVeracyte (NASDAQ:VCYT) Q1 2026 Earnings Call
Tue, May 05, 2026 · 4:30 PM ET
Watch TranscriptVeracyte (NASDAQ:VCYT) Q4 2025 Earnings Call
Wed, Feb 25, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Veracyte to Participate in Upcoming Investor Conferences
Oct 29, 2026
Closed $50.01 (-4.1%) on Oct 30, 2026
Phase III Trial Shows Veracyte’s Decipher Prostate Test Can Predict Benefit from Adding Abiraterone to Treatment in Very High-Risk Prostate Cancer
Oct 23, 2026
Closed $47.93 (+4.1%) on Oct 23, 2026
Six Studies to Highlight Veracyte’s Genomic Tests Across Breast, Prostate and Bladder Cancer at ESMO 2026
Oct 19, 2026
Closed $43.80 (+1.6%) on Oct 19, 2026
Veracyte Secures Medicare Reimbursement for Prosigna Breast Risk of Recurrence Test
Oct 16, 2026
Closed $43.12 (-2.9%) on Oct 16, 2026
Veracyte to Release Third Quarter 2026 Financial Results on November 4, 2026
Oct 14, 2026
Closed $44.39 (+2.0%) on Oct 15, 2026
Phase III Trial Demonstrates Veracyte’s Decipher Prostate Test Predicts Benefit from Adding Hormone Therapy to Radiation
Sep 29, 2026
Closed $46.08 (+1.9%) on Sep 29, 2026
Veracyte Announces Eight Decipher-Focused Studies to Be Presented at ASTRO 2026
Sep 25, 2026
Closed $45.23 (-0.4%) on Sep 28, 2026
Veracyte Acquires Convergent Genomics, Expanding its Urology Diagnostics Portfolio with a Urinary Tumor DNA Testing Platform
Sep 14, 2026
Closed $40.14 (-2.6%) on Sep 15, 2026
Veracyte to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
Sep 1, 2026
Closed $44.88 (+3.3%) on Sep 2, 2026
Veracyte Announces Second Quarter 2026 Financial Results
Jul 30, 2026
Closed $46.32 (-22.5%) on Jul 31, 2026
Decks
Q2 2026 Earnings Presentation
Earnings · 23 slides · Jul 30, 2026
Investor Presentation (June 2026)
Investor deck · 20 slides · Jun 1, 2026
Q1 2026 Earnings Presentation
Earnings · 22 slides · May 5, 2026
Raymond James Institutional Investor Conference 2026
Conference · 33 slides · March 2026
Veracyte, Inc. on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 28 in the last 12 months · 259 in all · newest Oct 29, 2026 · oldest 2019
- Calls
- 24 calls with a replay · 24 with a transcript · latest Jul 30, 2026
- Decks
- 19 decks · latest Jul 30, 2026
Where Veracyte, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:VCYT · Home listing | NASDAQ | United States | USD |
| gettex:12V | gettex | Germany | EUR |
| BOATS:VCYT | BOATS | United States | USD |
| LS Exchange:A1W7EA | LS Exchange | Germany | EUR |
| Lang & Schwarz:A1W7EA | Lang & Schwarz | Germany | EUR |
| Tradegate:12V · This page | Tradegate | Germany | EUR |
| Dusseldorf:12V | Dusseldorf | Germany | EUR |
| Frankfurt:12V | Frankfurt | Germany | EUR |
| Munich:12V | Munich | Germany | EUR |
| Hamburg:12V | Hamburg | Germany | EUR |
| Stuttgart:12V | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Veracyte, Inc.